The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126298392 12629839 2 F 2016 20160908 20160808 20160916 EXP US-SA-2016SA141499 AVENTIS 65.00 YR E F Y 66.67000 KG 20160916 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126298392 12629839 1 PS LANTUS SOLOSTAR INSULIN GLARGINE 1 Unknown DOSE:46 UNIT(S) U 6F2948A 21081 INJECTION QD
126298392 12629839 2 SS LANTUS SOLOSTAR INSULIN GLARGINE 1 Unknown DOSE:50 UNIT(S) U 6F2948A 21081 INJECTION QD
126298392 12629839 3 SS SOLOSTAR DEVICE 1 U 6F2948A 0 QD
126298392 12629839 4 C NIACIN. NIACIN 1 Oral 0 1 DF PROLONGED-RELEASE TABLET QD
126298392 12629839 5 C FENOFIBRATE. FENOFIBRATE 1 Oral 0 1 DF TABLET QD
126298392 12629839 6 C JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral 0 1 DF TABLET QD
126298392 12629839 7 C ZOCOR SIMVASTATIN 1 Oral 0 1 DF TABLET QD
126298392 12629839 8 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 0 1 DF TABLET QD
126298392 12629839 9 C VOLTAREN DICLOFENAC SODIUM 1 Transdermal APPLY SPARINGLY TO JOINT LEFT FOOT 0 GEL
126298392 12629839 10 C BENZONATATE. BENZONATATE 1 Oral 0 1 DF CAPSULE TID
126298392 12629839 11 C ACCU-CHEK 2 AVIVA PLUS IN VITRO STRIP?TEST 4 TIMES DAILY 0
126298392 12629839 12 C ACCU-CHEK 2 FASTCLIX LANCETS MISCELLANEOUS?TEST 4 X DAILY DX250 0
126298392 12629839 13 C GLYBURIDE. GLYBURIDE 1 Oral 0 2 DF TABLET BID
126298392 12629839 14 C NOVOLOG INSULIN ASPART 1 Subcutaneous DOSE:16 UNIT(S) 0 SOLUTION FOR INJECTION QD
126298392 12629839 15 C FLEXPEN UNSPECIFIED INGREDIENT 1 0 QD
126298392 12629839 16 C BYDUREON EXENATIDE 1 0
126298392 12629839 17 C ASPIR ASPIRIN 1 DELAYED RELEASE TABLET 0
126298392 12629839 18 C FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 0 TABLET
126298392 12629839 19 C METOPROLOL SUCCINATE. METOPROLOL SUCCINATE 1 Oral 0 25 MG PROLONGED-RELEASE TABLET QD
126298392 12629839 20 C NITROGLYCERIN. NITROGLYCERIN 1 0
126298392 12629839 21 C XALATAN LATANOPROST 1 INSTILL 1 DROP IN BOTH EYES AT BEDTIME. 0 1 GTT EYE DROPS, SOLUTION
126298392 12629839 22 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 0 TABLET
126298392 12629839 23 C ALBUTEROL SULFATE. ALBUTEROL SULFATE 1 INHALATION NEBULIZATION SOLUTION?EVERY 4-6 HOURS AS NEEDED DOSE:1 UNIT(S) 0
126298392 12629839 24 C ALBUTEROL SULFATE. ALBUTEROL SULFATE 1 INHALATION NEBULIZATION SOLUTION?EVERY 4-6 HOURS AS NEEDED DOSE:1 UNIT(S) 0
126298392 12629839 25 C ALBUTEROL SULFATE. ALBUTEROL SULFATE 1 INHALATION NEBULIZATION SOLUTION?EVERY 4-6 HOURS AS NEEDED DOSE:1 UNIT(S) 0
126298392 12629839 26 C SERTRALINE HYDROCHLORIDE. SERTRALINE HYDROCHLORIDE 1 Oral 0 3 DF TABLET QD
126298392 12629839 27 C METOCLOPRAMIDE HYDROCHLORIDE. METOCLOPRAMIDE HYDROCHLORIDE 1 Oral 0 1 DF TABLET TID
126298392 12629839 28 C REGLAN METOCLOPRAMIDE HYDROCHLORIDE 1 Oral 0 10 MG TABLET BID
126298392 12629839 29 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 0 1 DF CAPSULE QD
126298392 12629839 30 C LYRICA PREGABALIN 1 0 2 DF QD
126298392 12629839 31 C ZANTAC RANITIDINE HYDROCHLORIDE 1 0 1 DF QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126298392 12629839 1 Type 2 diabetes mellitus
126298392 12629839 2 Type 2 diabetes mellitus
126298392 12629839 3 Type 2 diabetes mellitus
126298392 12629839 4 Hypertriglyceridaemia
126298392 12629839 5 Hyperlipidaemia
126298392 12629839 6 Hyperlipidaemia
126298392 12629839 8 Hypothyroidism
126298392 12629839 23 Asthma
126298392 12629839 24 Bronchitis
126298392 12629839 25 Wheezing
126298392 12629839 26 Depression
126298392 12629839 27 Gastrooesophageal reflux disease
126298392 12629839 28 Gastrooesophageal reflux disease
126298392 12629839 29 Gastrooesophageal reflux disease

Outcome of event

Event ID CASEID OUTC COD
126298392 12629839 OT
126298392 12629839 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
126298392 12629839 Blood glucose increased
126298392 12629839 Device issue
126298392 12629839 Postoperative wound infection
126298392 12629839 Toe amputation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126298392 12629839 1 2015 0
126298392 12629839 2 2015 0
126298392 12629839 3 2015 0
126298392 12629839 4 20150526 0
126298392 12629839 5 20150407 0
126298392 12629839 6 20141006 0
126298392 12629839 8 20140220 0
126298392 12629839 9 20140703 0
126298392 12629839 10 20150512 0
126298392 12629839 13 20141021 0
126298392 12629839 14 20150908 0
126298392 12629839 15 20150908 0
126298392 12629839 23 20140404 0
126298392 12629839 24 20140404 0
126298392 12629839 25 20140404 0
126298392 12629839 27 20150721 0
126298392 12629839 29 20150423 0